Lyell Immunopharma, Inc. Common Stock (NASDAQ: LYEL) last traded at $7.51, down 9.19% on the session. The quote above updates while this page is open; the figures below are drawn from Lyell Immunopharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lyell Immunopharma, Inc. Common Stock trades on NASDAQ under the ticker LYEL. Its market capitalisation is $184.03 million.
Valuation measures for Lyell Immunopharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $184.03M |
|---|---|
| Enterprise value | $188.39M |
| Price / sales | 6816.06 |
| Price / book | 0.79 |
| Beta | 1.49 |
Trailing-twelve-month figures tagged in Lyell Immunopharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $27.0K |
|---|---|
| Net income (TTM) | -$248.48M |
| EPS (TTM) | -$12.65 |
| Operating margin | -949981.48% |
| Return on equity | -106.27% |
| Cash | $72.98M |
Range and volume for LYEL over the past 52 weeks.
| 52-week high | $45.00 |
|---|---|
| 52-week low | $7.39 |
| Volume | 187.2K |
| Average volume | 145.0K |
| Previous close | $8.27 |
Invest a chosen dollar amount in Lyell Immunopharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LYEL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.